Chan Thomas (TC): insider trades.
Chan Thomas (TC) reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Chan Thomas (TC)
Companies
| Company | Relationship | Transactions |
|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | Officer · Chief Accounting Officer | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | GoodRx Holdings, Inc. | F | 1,069 | $3.56 | 14,578 | Form 4 |
| 2026-09-15 | GoodRx Holdings, Inc. | M | 2,101 | — | 15,647 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | F | 1,342 | $3.73 | 11,316 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | F | 638 | $3.73 | 9,194 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | M | 2,636 | — | 12,658 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | F | 2,311 | $3.73 | 13,546 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | M | 1,686 | — | 10,880 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | F | 858 | $3.73 | 10,022 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | M | 4,541 | — | 15,857 | Form 4 |
| 2026-08-15 | GoodRx Holdings, Inc. | M | 1,252 | — | 9,832 | Form 4 |
| 2026-07-15 | GoodRx Holdings, Inc. | F | 2,947 | $3.01 | 8,580 | Form 4 |
| 2026-07-15 | GoodRx Holdings, Inc. | M | 5,792 | — | 11,527 | Form 4 |
Questions
What stock did Chan Thomas (TC) buy or sell?
Chan Thomas (TC) reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Chan Thomas (TC) the same person as other filers with this name?
This page covers SEC CIK 2131829 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/chan-thomas-tc-2131829.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.